A pharmacological master key mechanism that unlocks the selectivity filter gate in K + channels

Potassium (K ) channels have been evolutionarily tuned for activation by diverse biological stimuli, and pharmacological activation is thought to target these specific gating mechanisms. Here we report a class of negatively charged activators (NCAs) that bypass the specific mechanisms but act as mas...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Science (American Association for the Advancement of Science) 2019-02, Vol.363 (6429), p.875-880
Hauptverfasser: Schewe, Marcus, Sun, Han, Mert, Ümit, Mackenzie, Alexandra, Pike, Ashley C W, Schulz, Friederike, Constantin, Cristina, Vowinkel, Kirsty S, Conrad, Linus J, Kiper, Aytug K, Gonzalez, Wendy, Musinszki, Marianne, Tegtmeier, Marie, Pryde, David C, Belabed, Hassane, Nazare, Marc, de Groot, Bert L, Decher, Niels, Fakler, Bernd, Carpenter, Elisabeth P, Tucker, Stephen J, Baukrowitz, Thomas
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Potassium (K ) channels have been evolutionarily tuned for activation by diverse biological stimuli, and pharmacological activation is thought to target these specific gating mechanisms. Here we report a class of negatively charged activators (NCAs) that bypass the specific mechanisms but act as master keys to open K channels gated at their selectivity filter (SF), including many two-pore domain K (K ) channels, voltage-gated hERG (human ether-à-go-go-related gene) channels and calcium (Ca )-activated big-conductance potassium (BK)-type channels. Functional analysis, x-ray crystallography, and molecular dynamics simulations revealed that the NCAs bind to similar sites below the SF, increase pore and SF K occupancy, and open the filter gate. These results uncover an unrecognized polypharmacology among K channel activators and highlight a filter gating machinery that is conserved across different families of K channels with implications for rational drug design.
ISSN:0036-8075
1095-9203
1095-9203
DOI:10.1126/science.aav0569